IDEAYA Biosciences, Inc.
Price Action
Technical Summary
CONSOLIDATINGIDEAYA Biosciences, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 51), indicating performance broadly in line with the market. Earnings contraction of 35% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $29.59 | +5.55% | ABOVE |
| 50 SMA | $29.79 | +4.84% | ABOVE |
| 100 SMA | $31.17 | +0.20% | ABOVE |
| 150 SMA | $32.38 | -3.56% | BELOW |
| 200 SMA | $31.26 | -0.10% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is IDYA in an uptrend right now?
IDYA has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is IDYA overbought or oversold?
IDYA's RSI (14) is 59. The stock is in neutral territory, neither overbought nor oversold.
Is IDYA outperforming the market?
IDYA has a Relative Strength (RS) Rating of 51 out of 99. IDYA is performing about average compared to the market.
Where is IDYA in its 52-week range?
IDYA is trading at $31.23, which is 80% of its 52-week high ($39.28) and 57% above its 52-week low ($20.50).
How volatile is IDYA?
IDYA has a Beta of 1.23 and 52-week volatility of 48%. It's more volatile than the S&P 500 - expect bigger swings.